Microba Life Sciences Ltd
ASX:MAP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Alkhabeer REIT Fund
SAU:4348
|
SA |
|
Marketingforce Management Ltd
HKEX:2556
|
CN |
|
Microtek International Inc
TWSE:2305
|
TW |
|
Y
|
Yamana Gold Inc
LSE:AUY
|
CA |
Microba Life Sciences Ltd
Operating Income
Microba Life Sciences Ltd
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Microba Life Sciences Ltd
ASX:MAP
|
Operating Income
-AU$19.8m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
Sonic Healthcare Ltd
ASX:SHL
|
Operating Income
AU$976.7m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
6%
|
|
|
Integral Diagnostics Ltd
ASX:IDX
|
Operating Income
AU$71.1m
|
CAGR 3-Years
27%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Australian Clinical Labs Ltd
ASX:ACL
|
Operating Income
AU$68m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
Apiam Animal Health Ltd
ASX:AHX
|
Operating Income
AU$12.4m
|
CAGR 3-Years
9%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
H
|
Healius Ltd
ASX:HLS
|
Operating Income
AU$17.6m
|
CAGR 3-Years
-51%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
-14%
|
|
Microba Life Sciences Ltd
Glance View
Microba Life Sciences is a precision microbiome science company powering medical innovation to transform human health. The company is headquartered in Brisbane, Queensland. The company went IPO on 2022-04-05. The firm specializes in the analysis of gut microbiome and promotes development in pathology services, therapeutics and diagnostics based on the microbiome. The firm's flagship product is the Microba Insight, a sampling kit that allows the public to analyze personal gut microbiome. Its discovery platform uses human data and informatic approaches to connect microbial genotype to human phenotype. The company also offers support solutions to researchers.
See Also
What is Microba Life Sciences Ltd's Operating Income?
Operating Income
-19.8m
AUD
Based on the financial report for Jun 30, 2025, Microba Life Sciences Ltd's Operating Income amounts to -19.8m AUD.
What is Microba Life Sciences Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
-22%
Over the last year, the Operating Income growth was 6%. The average annual Operating Income growth rates for Microba Life Sciences Ltd have been -7% over the past three years , -22% over the past five years .
